glp-1 agonists and sglt2 inhibitors combination Concomitant use of receptor in patients with heart failure | Cardiovascular Diabetology – Endocrinology Reports Practical Considerations and Rationale for

The data consistently shows that: It reduces intrahepatic fat more effectively than most lifestyle interventions alone

It is associated with supporting overall skin clarity and influencing melanin production gradually, which may contribute to a more even-looking complexion over time

What survives that test is narrower and more testable than the broad claim it replaces: that brain-penetrant agonism, delivered early, in patients chosen by their biology rather than their diagnosis, and judged against biomarkers rather than questionnaires, might still work

These complementary mechanisms have led researchers to hypothesize that combining both compounds may yield synergistic effects on growth hormone secretion in laboratory settings

These include different GLP-1/GIP combinations with varying receptor affinity profiles, triple agonists that add glucagon activity, and oral formulations of dual agonists